Industries de la santé
€1 million funding secured from the Walloon Region to investigate these innovative products for the treatment of large bone defects
06 Janvier 2015
Gosselies, Belgium, 5 January 2015 - BONE THERAPEUTICS, the regenerative therapy company addressing unmet medical needs in the fields of fracture repair and bone fracture prevention, today announces that it has begun a new research project to investigate novel combined osteoblastic cell-matrix products for the treatment of large bone defects. The government of the Walloon Region has... |Plus d'articles...
- Prostate Cancer Medications Linked with Increased Risk of Heart-Related Deaths in Men with Cardiovascular Problems
- Nanion Technologies and Axion Biosystems Announce Strategic Distribution Partnership in Europe and China
- Global Aortic Stent Grafts Market Value to Exceed $1.9 Billion by 2020, says GlobalData
- Produits opérationnels et situation nette de trésorerie pour les neuf premiers mois de 2014